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Abstract: The aim of this work was to synthesize collagen α-tocopherulate for topical treatments. Collagen is a nat-
ural polymer largely applied to enhance wound repair, and α-tocopherol is a known antioxidant used for the treat-
ment of various skin diseases. Linking the two through covalent bonds could improve α-tocopherol transport and
metabolic stability, reduce the rate of degradation, and ensure a longer persistence than free antioxidant. The new
biopolymer was prepared by a solid-phase synthesis employing a carboxypolystyrene resin. Its antioxidant activity
in rat liver microsomal membranes was also evaluated. The obtained collagen-based biomaterial represents a new
prodrug of α-tocopherol that could be used for various biomedical applications.
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Introduction
Over the last decades, significant progresses have been
made in the development of biodegradable polymeric mater-
ials for biomedical applications. They are, at present, the
structures of choice for the development of therapeutic
devices, such as temporary prostheses, porous three-dimen-
sional structures, vehicles for the controlled and/or delayed
release of drugs and materials for tissue engineering.1 Actu-
ally, there are many biocompatible natural or synthetic
materials that can undergo hydrolytic or enzymatic degrada-
tion for biomedical applications.2 Among these, collagen is
considered as one of the most useful biomaterials. Its excel-
lent biocompatibility and its safety, mainly due to the biode-
gradability and weak antigenicity,3 make it one of the primary
resources in biomedical applications. The use of collagen as
a drug delivery system is very comprehensive and diverse:
the main applications are collagen shields in ophthalmol-
ogy, sponges for burns/wounds, mini-pellets, nanoparticles
and tablets for protein, and for transdermal delivery. In par-
ticular collagen sponges have been very useful in the treat-
ment of severe burns and as a dressing for many types of
wounds, such as pressure sores, donor sites, leg and decubi-
tus ulcers as well as for in vitro test systems.4 Collagen plays
an important role in the formation of tissues and organs, and
is involved in various functional expressions of cells. It is a
primary structural constituent of vertebrates, as well as the
most abundant protein in mammals, accounting for roughly
20%-30% of the total protein in the body. It is present in tis-
sues such as skin, bones, tendons and ligaments, with a pre-
dominantly mechanical function, and preserves, in addition,
the structural integrity of all internal organs. The structural
unit of collagen is represented by the tropocollagen, a pro-
tein with a molecular mass of approximately 285 kDa, com-
posed of three polypeptide chains that are associated with
left-handed pattern to form a right-handed triple helix. The
largest amount of collagen, which is currently used for bio-
medical applications, are obtained from the skin of cattle or
swine or bovine Achilles tendon. One disadvantage of these
collagen-based biomaterials and the limiting factor for their
clinical applications is their mild immunogenicity, given by
the composition of the terminal region of the chains. The
immune response was found to be different depending on
the species from which the collagen has been isolated, or on
the implant site; the immunogenicity was reduced by pre-
treatment of the protein before application. Other limits to
its use can also result from the high cost of pure collagen,
its poor chemical stability, the risk of transmission of infec-
tious diseases due to allogeneic or xenogeneic origin of the
material. Several recombinant systems are currently being
developed for the production of human collagen.5 This last
undergoes enzymatic degradation within the body by
enzymes such as collagenase and metalloproteinase, releas-
ing the corresponding aminoacids that compose itself. Since
collagen is the main component of the extracellular matrix
and acts as a natural substrate for cells connection, prolifer-
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ation and differentiation, it is understandable the increasing
interest in using it as an ideal material for the medical tis-
sutal engineering. When tissues are injured due to trauma,
collagen is needed to repair the defect and restore the struc-
ture and hence function. An excessive deposition of col-
lagen can induce fibrosis, compromising the structure and
the function of the damaged site. Conversely, if the quantity
of deposed collagen is insufficient, the tissue hardly under-
goes complete regeneration. A spongy matrix, containing
collagen and oxidized cellulose, has been recently intro-
duced in the European market for the treatment of exuding
wounds in patients with diabetic ulcers.6 Of great impor-
tance also its use as a substitute for skin in the treatment of
burn injury.7 Wound healing is a highly specified process
that starts with the formation of granulation tissue and ends
with scar formation. In most of the cases, the complication in
wound healing is the inflammation that results in a continu-
ous generation of reactive species, such as the superoxide
radical (O2-) or the non-radical hydrogen peroxide (H2O2),
which are now strongly implicated in the pathogenesis of
chronic wounds.8 Such a property is of significance to the
wound healing process, as despite the beneficial role that
ROS (reactive oxygen species) play in killing invading
microbial pathogens, excessive overproduction of ROS can
be detrimental to the host tissues by inactivating enzymic
antioxidants and significantly depleting non enzymic anti-
oxidants levels.9 Evidence for the potential role of oxidants
in the pathogenesis of many diseases suggests that antioxi-
dants may be of therapeutic use in these conditions.
The aim of the present work was to obtain a useful bioma-
terial antioxidant as a carrier system through the functional-
ization of collagen with α-tocopherol (vitamin E), a known
antioxidant molecule (Figure 1). The obtained biopolymer
is an α-tocopherol prodrug that could be used in the prepa-
ration of unconventional collagen-based drug delivery sys-
tems. Particularly, the synthesis was carried out in solid phase
by using a carboxypolystyrene resin.
Experimental
Materials. All solvents of analytical grade, were purchased
from Carlo Erba Reagents (Milan, Italy): dichloromethane,
diethylether, N-methylpyrrolidone, thionyl chloride, collagen
from bovine Achilles tendon (freeze-dried, insoluble), α-toco-
pherol, dicicloesilcarbodimmide (DCC), trifluoroacetic acid,
potassium chloride (KCl), ethylenediaminetetraacetic acid
(EDTA), sucrose, 4-2-hydroxyethyl-1-piperazineethane-
sulfonic acid (HEPES), trichloroacetic acid (TCA), hydro-
chloric acid, butylated hydroxytoluene (BHT), tert-butyl
hydroperoxide (tert-BOOH), and 2-thiobarbituric acid (TBA)
were purchased from Sigma-Aldrich (Sigma Chemical Co,
St. Louis, MO, USA). Resin (carboxypolystyrene HL, 100-
200 MESH, 1% DVB) was purchased from Merck AG. 
Infrared spectra were recorded on KBr pellets using a FT-
IR spectrometer Perkin-Elmer 1720. UV-vis spectra were
realized through a UV-530 JASCO spectrophotometer. The
samples were lyophilized utilizing a “Freezing-drying” Micro
moduly apparatus, Edwards. The calorimetric analyses (DSC)
were performed using a Netzsch DSC200 PC.
Collagen Derivatization. The derivatization reaction10,11
was carried out in a vial Disa, suitably flamed, under stir-
ring and nitrogenum atmosphere at room temperature for 3
h. In order to activate the carboxylic function available on
the resin, we generated the corresponding acyl chloride by
adding thionyl chloride (SOCl2, 0.022 mL, 0.3 mmol) in
slight excess in a ratio of 1.5:1 compared to the resin (0.2
mmol; 0.2 g). As reaction solvent we used N-methylpyrroli-
done, the only one that was able to solubilize the collagen
under heat treatment (70 oC) and stirring for a minimum of
40 min. After the activation of carboxylic groups present on
the resin with thionyl chloride, collagen (0.008 g) was added.
In this way the protein was covalently linked to the resin;
afterthat α-tocopherol and a coupling agent such as dicic-
loesilcarbodimmide (DCC) were added. We used a slight
excess of antioxidant (0.3 mmol, 0.129 g) respect to the
resin (0.2 mmol) and DCC (0.3 mmol, 0.062 g) in equal
amounts with α-tocopherol. Reaction was conducted at
room temperature for 72 h. In order to obtain the cleavage
of the derivatized protein from the resin, 0.5 mL of trifluo-
roacetic acid (TFA) 5% in 10 mL of dichloromethane (DCM)
were added. This reaction was conducted under nitrogen
atmosphere and continuous magnetic stirring. We performed a
filtration under reduced pressure on a porous filter. We got a
clear and yellow filtrate. The resin, after filtration and wash-
ing has been retained for reuse. The obtained product was
washed with several aliquots of diethyl ether, extracted with
chloroform, dried at reduced pressure and characterized
(Yield: 70%). 
Antioxidant Activity Evaluation through Rat Liver Microso-
mal Membranes. The antioxidant activity in inhibiting the
lipid peroxidation, in rat-liver microsomal membranes,
induced in vitro by a source of free radicals such as tert-butyl
hydroperoxide (tert-BOOH), was evaluated. Liver microsomes
were prepared from Wistar rats by tissue homogenization
with 5 volumes of ice-cold 0.25 M sucrose containing 5
mM Hepes, 0.5 mM EDTA, pH 7.5 in a Potter-Elvehjem
Figure 1. Schematic representation of collagen α-tocopherol-
linked.
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homogenizer.12 The microsomal membranes were isolated
by the removal of the nuclear fraction at 8,000 g for 10 min,
and by the removal of the mitochondrial fraction at 18,000 g
for 10 min. The microsomal fraction was sedimented at
105,000 g for 60 min, and the fraction was washed once in
0.15 M KCl, and was collected again at 105,000 g for 30
min.13 The membranes, suspended in 0.1 M potassium phos-
phate buffer, pH 7.5, were stored at -80 oC. Microsomal pro-
teins were determined by the Bio-Rad method.14
Aliquots of collagen derivative and of α-tocopherol in the
range of 0.5-6 mg/mL were added to the microsomes. These
microsomes were gently suspended by a Dounce homoge-
nizer, and then the suspensions were incubated at 37 oC in a
shaking bath under air in the dark.
Malondialdehyde (MDA) was extracted and analyzed as
indicated.15 Briefly, aliquots of 1 mL of microsomal suspen-
sion (0.5 mg proteins) were mixed with 3 mL of 0.5% TCA
and 0.5 mL of TBA solution (two parts 0.4% TBA in 0.2 M
HCl and one part distilled water), and 0.07 mL of 0.2%
BHT in 95% ethanol. The samples were then incubated in a
90 oC bath for 45 min. After incubation, the TBA-MDA
complex was extracted with 3 mL of isobutyl alcohol. The
absorbances of the extracts were measured by the use of UV
spectrophotometry at 535 nm, and the results were expressed
as percent of MDA inhibition, using an extinction coeffi-
cient of 1.56×105 L mmol-1 cm-1.
Results and Discussion
As evidenced by the abundance of data in literature, a
growing interest is now attributed to the design and imple-
mentation of biocompatible systems for pharmaceutical
applications. For these purposes, recently more and more
attention is directed to the use of natural polymers or com-
pounds synthesized from materials of natural origin that
best meet the needs of biocompatibility.16-18 The purpose of
this work was to synthesize a prodrug collagen-based and
therefore compatible with tissues to exploit its intrinsic
properties in order to convey the active ingredient bound to
collagen and facilitate tissue repair. 
Solid Phase Synthesis of Collagen Derivative. Since the
collagen is a highly composite protein, consisting of a huge
number of aminoacids, before to functionalize it with an
antioxidant, we performed a preventive treatment in order to
anchor the protein to a resin acting as a protecting group of
collagen terminal amino-group. After the collagen binding
to the resin through its amino-terminal group, and activation
of its C-terminal group with thionyl chloride, we proceeded
to the functionalization of the protein with a known antioxi-
dant agent, α-tocopherol, through the formation of an esther
bond. After that we cleaved the functionalized collagen
from the resin (Scheme I). 
In particular, we carried out a heterogeneous synthesis:
the ester-linkage between resin and protein has been facili-
tated by a prior chlorination of -COOH groups of the resin.
The formation of acylic chloride, with markedly electro-
philic character and hence more reactive than the corre-
sponding carboxyl function was carried out by treatment of
the resin, dissolved in N-methylpirrolidone, with thionyl
chloride. The choice to anchor the collagen on the resin sur-
face for its functionalization with α-tocopherol has been
considered mainly in order to avoid the difficulties in con-
ducting the synthesis, which could result from the excessive
size of the collagen itself. These problems inherent in the
protein matrix characteristic would have been difficult to be
managed in a more common synthesis in homogeneous
phase. Moreover, we chosed the heterogeneous synthesis to
facilitate the management of several functional groups in the
aminoacids side chain that constitute the collagen. Once the
N-terminal function of the polypeptide was locked, our
attention has been paid to the free functional groups on the
other side of collagen itself. Carboxylic acid functions, use-
ful for the functionalization with the α-tocopherol phenolic
hydroxyl group, are not only those C-terminals, but also
those exposed in the side chain of the amino acids constitut-
ing the protein. The bond between the resin acyl chloride
and the α-tocopherol hydroxyl group is a relationship of
ester. It is generated by reaction between the nucleophilic
Scheme I. Synthetic route.
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group (-OH), present on the antioxidant phenolic ring, and
the resin -COCl groups with a strong electrophile character.
The covalent bond of the antioxidant moiety on the collagen
matrix has something very important from the point of view
of the use of this product as a potential prodrug. The pro-
tein, in fact, possessing itself a therapeutic action, is enriched
and strengthened of the antioxidant properties. The resin can
be removed from the derivatized collagen by breaking the
ester bond. For this purpose we used, a mild acid treatment
which do not affect the ester bond between the protein and
the antioxidant. The resin was removed by filtration. The
filtrate was washed with diethyl ether to induce precipita-
tion of the product and thus allowing its separation and
recovery. The spectrum of non-derivatized collagen shows a
high amount of functional groups, relating to the numerous
side chains of amino acids that make up the structure. How-
ever, comparing starting collagen and functionalized one,
we noted the presence of typical bands of ester bonds (Fig-
ure 2).
The calorimetric analysis for commercial collagen revealed
the presence of a large endothermic at 207.1 oC. On the other
hand, the DSC spectrum of derivatized collagen, shows the
absence of the transition of commercial vitamin E (113 oC)
and the presence of a broad peak similar to that observed for
the non-derivatized collagen. 
Antioxidant Activity Evaluation. The collagen deriva-
tive was then tested for its antioxidant activity. The results
showed that collagen esterified with α-tocopherol possesses
protective activity against free radicals. The ability of col-
lagen derivative in inhibiting lipid peroxidation induced by
tert-BOOH, was examined in rat liver microsomal mem-
branes over 120 min of incubation. In order to draw com-
parisons with the non-functionalized collagen, even this has
been tested for its antioxidant capacity (data not shown).
The ability of the synthesized material to inhibit lipid perox-
idation is time-dependent, in addition the collagen deriva-
tive maintains the antioxidant activity and trend over time
of the commercial α-tocopherol (Figure 3). 
Conclusions
A growing interest is reserved, nowadays, in the research
and the development of natural or synthetic materials capa-
ble of combining the characteristics of biocompatibility
with the site-specificity against target organ.19-21 For these
same reasons we realized a prodrug composed of collagen
and α-tocopherol, in order to obtain a biocompatible carrier
with antioxidant properties. Evidence for the potential role
of oxidants in the pathogenesis of many diseases suggests
that the antioxidants may be of therapeutic use in these con-
ditions. To facilitate the peptide derivatization, we decided to
conduct the entire process in heterogeneous phase. On the col-
lagen derivative we carried out some analysis such as FTIR
spectroscopy and DSC analysis. Then we tested its antioxi-
Figure 2. IR analysis of ( ) C-αT, ( ) αT, ( ) C.
Figure 3. Percentage of inhibition of tert-BOOH induced MDA
formation in rat microsomal membranes. The microsomal mem-
branes were incubated with 0.25×10-3 M tert-BOOH at 37 oC
under air in the dark. The results represent the mean ± standard
error of the mean (SEM) of six separate experiments.
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dant efficacy on rat liver microsomal membranes, in order
to evaluate the antioxidant activity of functionalized col-
lagen. The data obtained by this procedure show that the
derivatized product maintains the typical α-tocopherol anti-
oxidant activity which is able to improve significantly
wound healing and protect tissues from oxidative damage. 
Aknowledgment. This work was financially supported
by Academic Funds and MIUR (Programma di Ricerca di
Rilevante Interesse Nazionale 2008).
References
(1) G. Pitarresi, F. S. Palumbo, G. Cavallaro, S. Fare, and G.
Giammona, J. Biomed. Mater. Res., 87A, 770 (2008).
(2) L. S. Nair and C. T. Laurencin, Prog. Polym. Sci., 32, 762
(2007).
(3) R. Timpl, in Extracellular Matrix Biochemistry, K. A. Piez
and A. H. Reddi, Eds., Elsevier, New York, 1984, pp 159-190.
(4) C. H. Lee, A. Singla, and Y. Lee, Int. J. Pharm., 221, 1 (2001).
(5) D. Olsen, C. Yang, M. Bodo, and R. Chang, Adv. Drug Deliv.
Rev., 55, 1547 (2003).
(6) F. Vin, L. Teot, and S. J. Measume, Wound Care, 11, 335 (2002).
(7) J. F. Thornton and R. J. Rohrich, Plast. Reconstr. Surg., 116,
677 (2005).
(8) M. J. White and F. R. Heckler, Clin. Plast. Surg., 17, 473
(1990).
(9) A. Sukla, A. M. Rasik, and G. K. Patnaik, Free Radic. Res.,
26, 93 (1997).
(10) F. Albericio, R. Chinchilla, D. J. Dodsworth, and C. Najera,
Org. Prep. Proced. Int., 33, 203 (2001).
(11) G. Sabatino, B. Mulinacci, M. C. Alcaro, M. Chelli, P. Rovero,
and A. M. Papini, Lett. Pept. Sci., 9, 119 (2002).
(12) V. L. Tatum, C. Changoit, and C. K. Chow, Lipids, 25, 226
(1990).
(13) S. Trombino, S. Serini, F. Di Nicuolo, L. Celleno, S. Andò, N.
Picci, G. Calviello, and P. Palozza, J. Agric. Food Chem., 52,
2411 (2004).
(14) M. M. Bradford, Anal. Biochem., 72, 248 (1976).
(15) A. E. Hagerman, K. M. J. Riedl, G. Alexader, K. N. Sovik, N.
T. Ritchard, T. Hartzfeld, and W. L. Riechel, J. Agric. Food
Chem., 46, 1887 (1998).
(16) R. Cassano, S. Trombino, T. Ferrarelli, R. Muzzalupo, L. Tavano,
and N. Picci, Carbohydr. Polym., 78, 639 (2009). 
(17) R. Cassano, S. Trombino, R. Muzzalupo, L. Tavano, and N.
Picci, Eur. J. Pharm. Biopharm., 72, 232 (2009). 
(18) R. Cassano, S. Trombino, T. Ferrarelli, E. Barone, V. Arena,
V. C. Mancuso, and N. Picci, Biomacromolecules, 11, 1139
(2010).
(19) X. Duan, C. McLaughlin, M. Griffith, and H. Sheardown,
Biomaterials, 28, 78 (2007).
(20) M. Radhika and P. K. Sehgal, J. Biomed. Mater. Res., 35, 497
(1997).
(21) M. Gruessner, P. V. Clemens, P. Pahlplatz, J. Sperling, and P.
Sperling, Am. J. Surg., 182, 502 (2001). 
